Repositioning of Etravirine as a Potential CK1ε Inhibitor by Virtual Screening
CK1ε is a key regulator of WNT/β-catenin and other pathways that are linked to tumor progression; thus, CK1ε is considered a target for the development of antineoplastic therapies. In this study, we performed a virtual screening to search for potential CK1ε inhibitors. First, we characterized the dy...
Saved in:
Main Authors: | Luis Córdova-Bahena (Author), Axel A. Sánchez-Álvarez (Author), Angel J. Ruiz-Moreno (Author), Marco A. Velasco-Velázquez (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profile of etravirine for the treatment of HIV infection
by: Alice Tseng, et al.
Published: (2010) -
Profile of etravirine in the treatment of HIV in pediatrics
by: Dehority W, et al.
Published: (2013) -
Etravirine Pharmacokinetics In HIV-Infected Pregnant Women
by: Nikki Mulligan, et al.
Published: (2016) -
Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
by: Hasan Afzaal, et al.
Published: (2022) -
Zebrafish as model system for the biological characterization of CK1 inhibitors
by: Laura Meier, et al.
Published: (2023)